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Abstract
We compared the presence of autistic and comorbid psychopathology and functional impairments in young adults who 
received a clinical diagnosis of Pervasive Developmental Disorders Not Otherwise Specified or Asperger’s Disorder during 
childhood to that of a referred comparison group. While the Autism Spectrum Disorder group on average scored higher on a 
dimensional ASD self- and other-report measure than clinical controls, the majority did not exceed the ASD cutoff accord-
ing to the Autism Diagnostic Observation Schedule. Part of the individuals with an ASD diagnosis in their youth no longer 
show behaviors that underscribe a clinical ASD diagnosis in adulthood, but have subtle difficulties in social functioning and 
a vulnerability for a range of other psychiatric disorders.
Keywords Autism spectrum disorder · Outcome · Young adult · Psychiatric comorbidity
Introduction
There has been a sharp rise in the measured prevalence of 
autism spectrum disorder (ASD) in the last decade. This 
rise has been accompanied by an increased interest and 
investment in research on ASD. Yet, most studies were 
focused on children and research on ASD in young adult-
hood is still scarce (Hartman et al. 2016; Howlin and Magiati 
2017). Limited data are available that describe topics like 
the symptom presentation of ASD in adulthood, the valid-
ity of diagnostic instruments in adulthood, the contribution 
of various sources of information to the diagnostic process 
(e.g. self- and other-report questionnaires, structured clini-
cal observation), and comorbidity with other psychiatric 
disorders. Because these are important components of the 
(differential) diagnosis of autism in adulthood, achieving a 
better understanding of these topics is especially relevant 
for more accurate diagnostic assessment in clinical practice. 
This is the case in particular when we have to distinguish 
milder forms of ASD from other forms of psychopathology 
or abnormal behavior (Hartman et al. 2016). In the recent 
past, patients with milder forms of ASD often received a 
diagnosis of PDD-NOS or, to a much lesser extent, Asper-
ger’s Disorder [according to the Diagnostic and Statisti-
cal Manual of Mental Disorders, fourth edition (DSM-IV, 
APA 2000)] in clinical care. The few available studies on 
the follow-up of these patients into adulthood suggest rela-
tively low reliability and stability of the PDD-NOS clas-
sification (e.g. Luteijn et al. 2000; Rondeau et al. 2011) and 
significant overlap with features of other disorders such as 
Attention Deficit Hyperactivity Disorder (ADHD, Louwerse 
et al. 2015; Verheij et al. 2015). Studies on adult outcome 
for children with Asperger’s Disorder also are scarce and 
mainly showed a high rate of psychiatric comorbidity in this 
group (Gillberg et al. 2016). In the current paper we aim to 
explore the manifestation of ASD and comorbidity in adults 
who had a clinical diagnosis of milder ASD during child-
hood or adolescence according to multiple perspectives (i.e. 
structured observation, other- and self-report).
Prospective studies from childhood into adulthood are 
an important source of information on adult ASD. These 
have shown that the vast majority of individuals diagnosed 
with autism in early childhood still meet clinical criteria 
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for autism in adulthood (e.g. McGovern and Sigman 2005; 
Billstedt et al. 2007). Seltzer et al. (2004) reviewed the 
retrospective, cross-sectional and prospective studies on 
symptom presentation and concluded that modest degrees 
of symptom abatement on all domains in adolescence and 
adulthood were the dominant pattern, but also found consid-
erable variability in course patterns. Since that review, more 
longitudinal studies were published in which individuals 
with a diagnosis of autism in early childhood were followed 
into adulthood (Billstedt et al. 2007; Howlin et al. 2013; 
Anderson et al. 2014) with findings largely in line with the 
conclusions from the Seltzer review. Various symptoms in 
the social interaction domain were still common in most 
adult patients. In the communication and restricted repeti-
tive behavior domains symptom abatement was more evident 
(Howlin et al. 2013). Functional outcome in terms of inde-
pendent living, employment status and social relationships 
was restricted for most individuals with ASD (e.g. Howlin 
et al. 2013; Gray et al. 2014). Childhood IQ and comorbid 
medical disorders, more than autism symptom severity, were 
associated with later outcome (Howlin et al. 2013).
There is to our knowledge only one longitudinal study on 
milder forms of ASD (i.e., PDD-NOS) in a sample without 
intellectual disability (IQ above 70). Louwerse et al. (2015) 
compared ADOS scores in childhood (ages 6–12) and at fol-
low up in adolescence (ages 12–20) in a group of 72 children 
with a clinical PDD-NOS diagnosis. Although ASD symp-
tom severity showed a large within stability, an important 
percentage of the participants both in childhood (46%) and 
adolescence (43%) did not meet criteria when applying the 
dichotomous ADOS ASD classification. Special educational 
needs and mental health care use were high, and number of 
reciprocal friendships were low in both assessment waves, 
especially in adolescents with a higher level of ASD symp-
tom severity. The study had no clinical reference group. We 
conclude that there is limited information on the adult out-
come of ASD especially where this concerns individuals on 
the milder end of the spectrum (like PDD-NOS in DSM-IV), 
both on symptomatic and on functional aspects.
One aspect of information that may contribute to our 
understanding of adult ASD is the use of multi-informant 
data. Self-report data provide information on the subjec-
tive experience of autistic symptoms which are lacking 
in the above-mentioned studies. Other-report data poten-
tially provide more information on behaviors that can be 
observed given limited insight of (some) persons with 
ASD in their social and repetitive behavior (Horwitz et al. 
2016). In child psychiatry research on agreement and dif-
ferences observed among multiple informants’ report of 
behavior has a long tradition, with consensus on the need 
to have both perspectives for a comprehensive view on 
the child’s problems. This is in contrast to research and 
clinical practice in adult psychiatry which mostly uses 
self-report. Parents tend to report more autistic behaviors 
in their underage children with ASD than these children 
report themselves (e.g. Johnson et al. 2009; Lerner et al. 
2012). Multi-informant data in adults are scarce. Differ-
ences in self- and other-report of autistic behavior between 
adults with ASD and those with other psychopathology 
may increase our understanding of the differential diag-
nosis of this behavior in adults.
This also holds for comorbid psychopathology, in par-
ticular in relation to differentiation from other mental dis-
orders. A growing body of evidence suggests a high rate 
of psychiatric comorbidity in children, adolescents and 
adults with ASD (Lai et al. 2019). Comorbidity is linked 
with symptom severity (e.g., Sprenger et al. 2013). Study-
ing a group of children with PDD-NOS, De Bruin and col-
leagues (2007) concluded that compared to those without 
comorbid psychiatric disorders, children with a co-morbid 
disorder had more deficits in social communication. Comor-
bidity in childhood has been shown to influence the course 
of ASD symptomatology and to be associated with poorer 
functional outcome and quality of life (e.g. Mazzone et al. 
2013). Four studies have systematically assessed the pres-
ence of comorbid psychiatric conditions in adults with ASD 
by semi-structured diagnostic interviews. A majority of the 
patients met criteria for more than one lifetime comorbid 
disorder, most notably major depressive disorder (54–77%), 
anxiety disorders (50–59%), and ADHD (30–69%). These 
rates were comparable to a clinically referred sample with-
out ASD (Joshi et al. 2013). No differences in comorbidity 
rates were found between males and females (Hofvander 
et al. 2009), and between individuals diagnosed with ASD 
in childhood and those who were diagnosed with ASD in 
adulthood (Lugnegård et al. 2011). Lever and Geurts (2016) 
reported that ASD severity, as indicated by the Autism Spec-
trum Quotient (AQ: Baron-Cohen et al. 2001) self-report 
and ADOS score, was predominantly associated with anxi-
ety severity and less with an anxiety diagnosis. Number of 
comorbid diagnoses did not seem to have a significant influ-
ence on daily functioning and subjective wellbeing (Lever 
and Geurts 2016).
The aim of this study was to investigate how patients 
who had received an earlier PDD-NOS or Asperger diag-
nosis before the age of 19 in specialist child and adolescent 
mental health care differed from other patients without ASD 
referred to specialist healthcare, with respect to current ASD 
symptoms (self- versus other-reported), comorbid diagnoses, 
and functional outcomes (mental health care use, medication 
use, educational attainment, social functioning). Data came 
from the clinical cohort of the Tracking Adolescents’ Indi-
vidual Lives Survey (TRAILS CC; Oldehinkel et al. 2015). 
Respondents were originally recruited at age ~ 11 based on 
previous referral to a secondary care mental health outpa-
tient clinic; we currently report on them at age ~ 19.





The study is based on data from the clinical cohort of the 
Tracking Adolescents’ Individual Lives Survey (TRAILS 
CC), a prospective study aiming to explain the develop-
ment of mental health from early adolescence (approxi-
mately age 11) into adulthood, with bi- or triennial assess-
ments. The clinical cohort for TRAILS runs parallel to the 
TRAILS general population cohort. The TRAILS study 
has been described in detail elsewhere (Oldehinkel et al. 
2015). The clinical cohort started in 2004 and consists 
of 543 individuals who had been referred to a child psy-
chiatric outpatient clinic in the Northern Netherlands any 
time before the age of 11. The data we present here were 
mainly collected in the fourth assessment wave of TRAILS 
at which the participants were approximately 19 years old.
The TRAILS CC data were linked to the Psychiatric Case 
Register Northern Netherlands (PCRNN). The PCRNN reg-
isters specialist child, adolescent and adult mental health 
care consumption in the three Northern provinces of the 
Netherlands (population 1.7 million), which overlaps with 
the area from which TRAILS participants were recruited. 
Children and their parents gave consent to link their TRAILS 
data to health care records in the PCRNN. The PCRNN con-
tained data from 2000 up (4 years preceding the start of 
TRAILS) on clinical diagnoses.
In the present study we compared 162 participants with 
an autism spectrum diagnosis (Asperger or PDD-NOS) 
diagnosed before the age of 19 to the remainder of the 
participants (n = 377) in the TRAILS CC cohort who were 
referred for different psychiatric problems (Fig. 1). At age 
19, 389 participants and their parents completed self- and 
other rating version of the ASBQ, and 345 completed the 
Composite International Diagnostic Interview (CIDI, Kes-
sler et al. 2004), all at the fourth assessment wave.
As an add-on study in TRAILS CC, we invited all par-
ticipants with a DSM-IV classification 299.80 (Asperger’s 
Disorder or Pervasive Developmental Disorder- not other-
wise specified) according to the PCRNN (n = 162) to take 
part in the ADOS assessment. In addition, we selected 
a random comparison group of 29 participants from the 
non-ASD diagnosed part (according to the PCRNN) of 
the clinical cohort to compare ADOS scores. Most of them 
had a primary diagnosis of ADHD (n = 18), the other par-
ticipants in this group had a wide variety of primary psy-
chiatric diagnoses.
The current study also used data on the functional sta-
tus of participants from the general population sample 
of TRAILS. This was done for educational attainment 
and number of social contacts, with the aim to compare 




The ASD and non-ASD clinical comparison group were 
compared on intelligence and demographic characteristics 
as measured at age 11 (baseline). Intelligence was measured 
on the basis of the Vocabulary and Block Design subtests of 
the Revised Wechsler Intelligence Scales for Children lead-
ing to approximate IQ scores (Silverstein 1967). Further, we 
measured the following socio-demographic variables at age 
19: gender, age, parental SES, educational attainment, use 
of medication, consultation of mental health care in the last 
six months before assessment, current job or type of ben-
efits, and number of social contacts. Self-report scores were 
supplemented with parent-report scores where appropriate.
ASD Questionnaires
The presence of ASD symptoms was assessed at baseline 
(age 11) using the Social Communication Questionnaire 
(SCQ; Berument et al. 1999) and at wave 4 (age 18–19) 
using the Adult Social Behavior Questionnaire (ASBQ; 
Horwitz et al. 2016). The SCQ is a screening tool to iden-
tify children at risk for ASD. Its 40 items are based on the 
Autism Diagnostic Interview—Revised (ADI-R, Lord et al. 
1994) and focus on the presence of ASD behaviors during 
early childhood. The authors defined a cutoff value of 15 
for ASD with a sensitivity of 0.85 and a specificity of 0.75. 
Schwenck and Freitag (2014) found an optimal cutoff value 
of 14–15 to differentiate ASD and ADHD in children with a 
normal intelligence (sensitivity 0.68, specificity 0.92), and 
an optimal cutoff of 11 to differentiate children with ASD 
and typically developing children in this group (sensitivity 
0.92 and specificity 0.87). We used the SCQ scores to deter-
mine the likelihood of an ASD diagnosis, and its severity, 
based on developmental history.
The ASBQ is a quantitative measure of autistic traits with 
subscales that allow a differentiated description of ASD 
problems. Factor analysis provided support for six homoge-
neous subscales that concurred in the self- and other-report 
versions: reduced contact, reduced empathy, reduced inter-
personal insight, violation of social conventions, insistence 
on sameness and sensory stimulation/motor stereotypies. 
Reliability estimates and correlations between self- and 
parent-ratings were good and the score profile on the 44-item 
ASBQ differentiated a group with ASD from a non-clinical 
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group and patients with other diagnoses (Horwitz et al. 
2016). We used both the self- and other-report version.
Observation of ASD Behavior
The Autism Diagnostic Observation Schedule—Module 4 
(ADOS, Lord et al. 1999, module 4 for verbally fluent adults) 
is a standardized, semi-structured observational assessment 
of social interaction, communication and restricted and 
repetitive behaviors that is used in the diagnosis of ASD. 
Although the ADOS is not designed to be used in isola-
tion in the diagnostic assessment of ASD, its discriminant 
validity in a population with a milder form of the spectrum 
has been reported as excellent (Fusar-Poli et al. 2017). An 
ADOS classification was originally based on thresholds on 
Social Interaction, Communication and on their combination 
TRAILS Tracking Adolescents’ Individual Lives Survey, SCQ Social Communicaon Quesonnaire, 
ASBQ Adult Social Behavior Quesonnaire, CIDI Composite Internaonal Diagnosc Interview, ADOS 
Ausm Diagnosc Observaon Schedule
¹ The TRAILS populaon cohort was used as a normave sample to interpret level of social 
funconing of the clinical groups; results are described in the Discussion secon.
TRAILS Cohort(n=2773)
TRAILS Clinical Cohort (TRAILS CC) n=543)
ASD group (n = 166)
SCQ T1 (n=162)









ASBQ self- and other 
report T4 (n=230)
CIDI T4 (n=183)











Fig. 1  Flow chart showing how the study samples were selected from the TRAILS cohort
Journal of Autism and Developmental Disorders 
1 3
(original algorithm, Lord et al. 1999). In 2014, Hus and Lord 
published a revised algorithm, containing a Social Com-
munication domain and a Repetitive Restricted Behavior 
domain (revised algorithm, Hus and Lord 2014). They found 
satisfactory sensitivity of 90% and specificity of 82% of the 
classification, and confirmation of the applicability of the 
two-domain structure of the DSM5 in the revised algorithm 
of module 4. In the current study the ADOS was adminis-
tered and scored by trained and certified psychologists.
Psychiatric (Co‑)Morbidity
TRAILS assessed the presence of mental disorders based on 
the Diagnostic and Statistical Manual of Mental Disorders, 
fourth edition (DSM-IV, APA 2000) at T4 using the com-
puter -assisted CIDI 3.0. The World Mental Health Organi-
zation Composite International Diagnostic Interview (CIDI, 
Kessler et al. 2004) is a structured diagnostic interview that 
can be administered by trained lay interviewers. The CIDI 
3.0 assesses age of onset and 30-day, 12-month and lifetime 
prevalence estimates of any disorder. In this study we used 
the lifetime prevalence estimates. Based on Ormel et al. 
(2014) the diagnoses were grouped according to four major 
diagnostic classes: mood disorders (major depressive dis-
order, dysthymic disorder, and bipolar disorder I and II), 
anxiety disorders (panic disorder, agoraphobia, social pho-
bia, specific phobia, generalized anxiety disorder, separa-
tion anxiety disorder, and obsessive–compulsive disorder), 
behavior disorders (attention deficit/hyperactivity disorder, 
oppositional defiant disorder, and conduct disorder) and sub-
stance use disorders (alcohol abuse/dependence, drug abuse/
dependence). Eating disorders, schizophrenia, personality 
disorders, adjustment disorders and autism spectrum disor-
ders were not assessed in the TRAILS CIDI.
Analyses
Descriptive analyses were conducted to examine the fre-
quency of outcomes across the diagnostic subgroups. Dif-
ferences between the ASD group and the clinical non-ASD 
comparison group means on demographic variables were 
examined using Student’s t test or chi-squared test, as appro-
priate. Group differences in SCQ scores and ASBQ self- and 
other- report scores between the ASD group and the clinical 
non-ASD comparison group were analyzed using multivari-
ate general linear modeling (GLM) on the subscales of the 
SCQ and the ASBQ simultaneously. This multivariate test 
was followed up by univariate GLM analyses per subscale of 
the SCQ and the ASBQ. We further examined the difference 
in ASBQ scores in participants with and without psychiatric 
comorbidity (‘any disorder lifetime’ on CIDI) in the ASD 
group by a t test.
Mean ADOS scores on the original and the revised algo-
rithm of the ASD group were compared to those of a clinical 
non-ASD comparison group using Student t test. Subjects 
within the ASD group with a revised algorithm ADOS score 
above and under autism spectrum cut-off were compared 
on SCQ scores at T1 and comorbid psychiatric diagnoses 
according to CIDI lifetime scores at T4.
We further examined differences between ASD- and clini-
cal non-ASD comparison groups in CIDI scores using Stu-
dent t tests and functional status at T4 using chi-squared test.
Effect sizes of between group differences were calculated 
using Cohen’s d, where d ≥ 0. 2 is considered ‘small’, d ≥ 0.5 
is considered ‘medium’ and d ≥ 0.8 is considered ‘large’ 
(Rea and Parker 1992). We used an alpha level of 0.01 in 
the analyses.
Results
Table 1 shows differences between the ASD and the clinical 
non-ASD comparison group in demographic characteristics 
and developmental history ASD status, and current health 
care use. A larger percentage of males comprised the ASD 
group than the clinical reference group. Higher IQ scores 
were found in the ASD group. Differences between the 
ASD group and the clinical non-ASD comparison group 
in SCQ scores were identified using a multivariate GLM 
analysis with group as a fixed factor and the three SCQ sub-
scale scores as the dependent measures (F = 8.806; df = 3; 
p < 0.001). Subsequent univariate GLM analyses for the total 
SCQ, and the SCQ subscales separately, showed that groups 
differed from each other on the total SCQ scale (F = 30.227; 
df = 1; p < 0.001) and the subscales (all three univariate p 
values ≤ 0.001).
Table 2 and Fig. 2 show the mean ASBQ total and sub-
scale scores per sample. A multivariate GLM analysis with 
group as a fixed factor and the six ASBQ subscales as the 
dependent measures showed an overall difference for both 
the other-report version (F = 7.872; df = 6; p < 0.001) and the 
self-report version (F = 3.509; df = 6; p = 0.002). Univari-
ate GLM analyses for the total ASBQ, and the ASBQ sub-
scales separately, indicated that groups differed from each 
other on parent scores on the total ASBQ scale (F = 31.717; 
df = 1; p < 0.001) as well as on all subscales (all six uni-
variate p values < 0.001). For self report scores the differ-
ences were significant for the total ASBQ scale (F = 9.032; 
df = 1; p = 0.003) and the reduced contact scale (p = 0.001), 
the reduced empathy scale (p = 0.001) and the insistence on 
sameness scale (p = 0.007), but not for the reduced social 
insight scale, the violation of social conventions and the sen-
sory stimulation & motor stereotypies scales. 
Only thirty of the 162 patients in the ASD group exceeded 
ADOS ASD cut-off on the ’original algorithm’, compared 
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to 1 patient in the non-ASD subsample of TRAILS CC 
(n = 29). Using the new algorithm this ratio was 31 of 162 
patients (the same 30 as with the original algorithm plus 1) 
in the ASD group and 1 of 29 (the same as with the original 
algorithm) patients in the control group. ADOS-2 scores on 
subscales and total scores according to both the original and 
the revised algorithm are shown in Table 3. Scores on all 
scales were higher in the ASD group, but differences on the 
communication scale (original algorithm) and the restricted 
repetitive behavior scale (revised algorithm) did not reach 
statistical significance.
A substantial lifetime prevalence of psychiatric comor-
bidity according to the CIDI (Table 4) was found in both 
groups and group differences were not significant. In the 
ASD group, ASBQ scores were on average higher in par-
ticipants with a comorbid disorder (any DSM IV disorder 
according to the CIDI). These differences reached signifi-
cance (p < 0.01; Student t test) in self-report on the sub-
scales violation of social conventions (mean score in ASD 
participants with comorbidity 0.32 vs. 0.20 in ASD partici-
pants without comorbidity), sensory stimulation & motor 
stereotypies (0.28 vs. 0.16), insistence on sameness (0.84 
vs. 0.58) and the total scale (19.47 vs. 13.69). Patients in the 
ASD group who exceeded ADOS ASD cut-off on the revised 
algorithm had fewer comorbid disorders according to the 
CIDI than those who scored under ADOS cut-off (Table 5).
The far majority of participants in both groups partici-
pated in education, training or work, with only a few receiv-
ing social security or disability benefits (Table 6). We addi-
tionally compared the educational attainment of our clinical 
groups with the TRAILS normative population sample (not 
included in Table 6), and found that participants from both 
the ASD group and the clinical control group were less often 
in higher education than participants from the normative 
sample (18% and 17% vs. 34%), while more clinical partici-
pants than those from the normative sample were in voca-
tional education (52% and 54% vs. 40%); these differences 
were statistically significant at p < 0.01 (2-sided t test). Most 
participants mentioned contacts with friends on a regular 
basis, in fact more so in the ASD group (approximately 
equal to the normative group) than in the clinical non-ASD 
comparison group. However, more parents from participants 
in the clinical groups than in the normative group estimated 
their child to have fewer friends than her son or daughter 
would have liked, with no differences between the clinical 
groups. More participants in the ASD group than in the clin-
ical non-ASD comparison group used psychoactive medica-
tion or had contacts with specialized mental health service 
over the last 6 months.
Discussion
In this study we investigated the symptomatic and functional 
characteristics of young adults who had been diagnosed with 
PDD-NOS or Asperger’s Disorder before age 19 in regular 
secondary mental health care. We compared their outcomes 
with those in a group of young adults previously diagnosed 
in the same mental health institution with other forms of 
psychopathology. We found that the self- and other report 
scores of autistic behavior on the ASBQ were higher in the 
ASD group, but not on all subscales. Most patients in this 
group did not meet the ADOS criteria for an ASD diagno-
sis in young adulthood. In both groups a high prevalence 
of multi-type comorbid psychiatric disorders was found. 
Compared to normative functioning, functional outcomes 
Table 1  Differences between the ASD and the non-ASD clinical comparison group on demographic and developmental history characteristics
PCRNN Psychiatric Case Register North Netherlands, WISC Wechsler Intelligence Scale for Children, SES Social Economic Status, sd standard 
deviation, n.s. not significant
ASD group (n = 162) Clinical non-ASD compari-
son group (n = 377)





 Gender (% male) 74% 62% p < 0.01 0.32
 Age (years) T4 [mean (sd)] 19.06 (.70) 19.15 (.75) n.s − 0.12
 SES T1 Lowest 25% 18% 27% n.s 0.25
  Middle 50% 52% 50% n.s 0.04
  Highest 25% 30% 23% n.s 0.21
 IQ (WISC) T1 [mean (sd)] 100.07 (14.65) 95.25 (15.67) p = 0.001 0.32
Developmental history ASD status (age 11)
 SCQ social interaction [mean (sd)] 4.64 (3.52) 2.94 (2.86) p < 0.001 0.53
 SCQ communication [mean (sd)] 4.51 (2.36) 3.83 (2.14) p = 0.001 0.30
 SCQ stereotypic behavior [mean (sd)] 2.39 (2.00) 1.66 (1.82) p < 0.001 0.38
 SCQ total [mean (sd)] 12.29 (6.56) 8.92 (5.67) p < 0.001 0.55
Journal of Autism and Developmental Disorders 
1 3
in terms of educational attainment and social contacts in 
the ASD group were less restricted than reported in previ-
ous studies.
Most young adults in our ASD group had received a 
PCRNN DSM-IV classification 299.80, which corresponds 
to a clinical diagnosis of PDD-NOS or Asperger’s Disorder. 
Clinical experience in the Netherlands (Greaves-Lord et al. 
2013) is that the classification 299.80 has been commonly 
used for the diagnosis PDD-NOS. The mean total SCQ 
score in the ASD group was 12.30, under the cutoff of 15 
for ASD as defined by Berument et al. in their original study 
(Berument et al. 1999), but above the cutoff of 11 found 
by Schwenck and Freitag (2014) to optimally differentiate 
ASD and normal controls. This supports the impression that 
our ASD group consisted mainly of children on the milder 
end of the autism spectrum [severity level 1 according to 
the DSM-5 (American Psychiatric Association 2013)] or in 
some instances even outside the spectrum.
Although ASBQ scores in the present ASD group were 
higher than in the clinical non-ASD comparison group, 
scores in both groups were lower compared to those in a 
previous study by our group (Horwitz et al. 2016). This is 
consistent with the samples studied. In the previous study 
we included patients who were recently referred to a mental 
health care center and diagnosed with ASD, with high lev-
els of distress. The current sample had had contact with an 
Table 2  Differences between 
the ASD and the non-ASD 
clinical comparison group on 
other- and self report autistiform 
behavior [ASBQ; mean (sd)]
ASD Autism Spectrum Disorder, ASBQ Adult Social Behavior Questionnaire, contact reduced contact, 
empathy reduced empathy, conventions violation of social conventions, insight reduced social insight, 
rigidity insistence on sameness, sensory sensory stimulation & motor stereotypies, sd standard deviation, 
n.s. non significant
a df = 1
ASD group (n = 159) Clinical non-ASD com-
parison group (n = 230)
Group dif-





 ASBQ contact 3.54 (3.25) 1.64 (2.39) 42.821 0.67
p < 0.001
 ASBQ empathy 4.81 (4.13) 3.07 (3.78) 15.735 0.44
p < 0.001
 ASBQ conventions 2.42 (2.97) 1.68 (2.43) 7.994 0.28
p < 0.001
 ASBQ insight 3.87 (3.32) 2.38 (2.64) 21.864 0.50
p < 0.001
 ASBQ rigidity 6.72 (4.44) 4.60 (4.31) 7.407 0.47
p < 0.001
 ASBQ sensory 1.06 (1.91) .60 (1.39) 21.445 0.26
p < 0.001
 ASBQ total score 22.42 (15.21) 13.98 (13.23) 31.717 0.59
p < 0.001
Self report
 ASBQ contact 2.32 (2.64) 1.52 (1.95) 10.832 0.35
p = 0.001
 ASBQ empathy 2.18 (2.55) 1.35 (2.10) 12.319 0.36
p = 0.001
 ASBQ conventions 1.67 (1.82) 1.79 (1.76) 0.285 -0.06
n.s
 ASBQ insight 3.30 (3.38) 2.49 (2.58) 5.992 0.27
p = 0.015
 ASBQ rigidity 6.04 (4.36) 4.51 (3.78) 0.720 0.38
p = 0.007
 ASBQ sensory 1.91 (2.58) 1.67 (2.30) 7.344 0.09
n.s
 ASBQ total score 17.42 (12.60) 13.35 (10.60) 9.032 0.35
p = 0.003
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outpatient clinic some time before age 11; participants were, 
therefore, not recruited on the basis of ASD nor on referral 
at the start of the study or at age 19. Like in our previous 
study, we found higher scores in the ASD group compared to 
other diagnostic groups on the ASBQ other-report, here with 
small to medium effect sizes. These differences were smaller 
on the ASBQ self-report, probably due to reduced disease 
insight in patients with ASD (Bishop et al. 2012). In line 
with this, scores on the other-report subscales in the ASD 
group were higher than scores on the self-report subscales.
Consistent with the core problems of ASD in adult-
hood, differences between groups were largest on reduced 
Fig. 2  Mean ASBQ self- and 

























Table 3  Differences between 
the ASD and the non-ASD 
clinical comparison group in 
scores on the Autism Diagnostic 
Observation Scale [ADOS-2, 
module 4; mean (sd)]











 Communication 1.43 (1.38) 1.10 (1.16) n.s 0.26
 Reciprocal social interaction 2.80 (2.34) 1.90 (1.45) p < .001 0.46
 Communication and social 
interaction (total score)
4.23 (3.17) 3.00 (2.08) p < 0.01 0.39
Revised algorithm
 Social affect 3.21 (3.13) 2.03 (2.04) p < 0.01 0.45
 Restricted repetitive behavior 1.41 (1.47) 1.17 (1.29) n.s 0.19
 Social affect and restricted 
repetitive behavior (total 
score)
4.62 (4.05) 3.20 (2.44) p < 0.01 0.38
Table 4  Differences between 
the ASD and the non-ASD 
clinical comparison group 
in the prevalence of lifetime 
psychiatric conditions (CIDI)
ASD Autism Spectrum Disorder, CIDI Composite International Diagnostic Interview, mood any mood dis-










CIDI mood lifetime 27% 21% n.s 0.14
CIDI anxiety lifetime 31% 41% n.s 0.02
CIDI behavior lifetime 28% 24% n.s 0.11
CIDIsubstance lifetime 15% 9% n.s 0.07
CIDI any disorder llifetime 30% 56% n.s 0.16
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contact, reduced empathy, reduced social insight and 
insistence on sameness subscales. On subscales violation 
of social conventions and sensory stimulation & motor 
stereotypies the differences between ASD and other groups 
were smallest (Table 2; Fig. 2). These results confirm the 
findings from our previous study on the ASBQ (Horwitz 
et al. 2016), in which we compared ASBQ self- and other 
report scores of patients with ASD with comparison 
groups ADHD, schizophrenia and depression and a non-
clinical group. The fact that in the clinical reference group 
ADHD was a common diagnosis may explain the limited 
difference on the violation of social convention scale. 
ASD and ADHD show an overlap at the behavioral level; 
they have shared struggles with social rules, in ADHD 
expressed as social rudeness due to impulsivity and disin-
hibition (Nijmeijer et al. 2008) rather than reduced under-
standing of social rules. Given that the revised criteria in 
the DSM-5 allow a combined ASD and ADHD classifica-
tion and behaviors pertaining to these diagnoses might 
look similar, accurate analysis of the context and mean-
ing of these behaviors to determine whether they are part 
of ASD, ADHD or both is necessary to adequately treat 
and coach patients. The use of information gathered from 
both from the patient and from informants (by means of 
psychiatric interviews and questionnaires) can improve the 
quality of the diagnostic process.
Table 5  SCQ scores at T1, 
CSBQ scores at T1 and CIDI 
scores at T4 [mean (sd)] in 
ASD- ADOS positive and 
-ADOS negative subgroups
SCQ Social Communication Questionnaire, CSBQ Children’s Social Behavior Questionnaire, ADOS 
Autism Diagnostic Observation Scale, CIDI Composite International Diagnostic Interview, sd standard 
deviation, n.s. not significant
ADOS above cutoff 
(n = 29)
ADOS under cutoff 
(n = 133)
Group differences




SCQ Total (T1) 13.82 (7.18) 11.17 (6.27) n.s 0.39
CSBQ Total (T1) 33.34 (14.84) 32.14 (16.24) n.s 0.08
CIDI lifetime T4
0 57% 32% p < 0.01 0.57
1 39% 31% n.s 0.19
 > 1 4% 37% p < 0.01 -1.46
Table 6  Differences between the ASD and the non-ASD clinical comparison group in functional outcomes at T4 (work, education, social con-
tacts, mental healthcare use)
PCRNN Psychiatric Case Register North Netherlands, ASD ASD group, non-ASD non-ASD group, Norm Normative group, n.s. not significant, 
sd standard deviation
PCRNN ASD group 
(n = 161)
PCRNN non-ASD 





Working 12% 7% n.s 0.33
Disability benefit 6% 5% n.s 0.11
Social welfare 1% 1% n.s 0
Pre-vocational education 2% 1% n.s 0
Vocational education 52% 54% n.s 0
Higher secondary education 8% 12% n.s − 0.25
Higher education 18% 17% n.s 0.04
Number of sick days in last 3 months [mean, (sd)] 2.9 (3.0) 1.7 (2.1) n.s 0.46
Social contacts
Meeting friends at home ≥ once a week 71% 49% p < 0.01 0.52
Meeting friends outside home ≥ once a week 27% 29% n.s -0.05
Going out ≥ once a week 38% 31% n.s 0.17
Having fewer friends than son/daughter would like (par-
ent score)
15% 24% n.s -0.32
Current mental healthcare use
 On psychiatric medication 33% 16% p < 0.01 0.27
 On non-psychiatric medication 10% 13% n.s 0.06
 Contacts mental healthcare last 6 months 33% 11% p < 0.01 0.39
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Considering the low scores on the sensory stimulation & 
motor stereotypies subscale, the behavior and experiences 
tapped by this scale are relatively uncommon in less severe 
forms of ASD. We conclude that young adults with a pre-
vious PDD-NOS or Asperger diagnosis differ from other 
diagnostic groups on the social and insistence on sameness 
problem domains, but not on sensory-motor stereotypies nor 
on overt out of context social acts.
We expected that in this sample with relatively mild autis-
tic behavioral problems in childhood, few of the patients 
would receive an adult ADOS ASD classification (cf. Lou-
werse et al. 2015), but that there would be higher average 
scores in the ASD group compared to the comparison group 
on a dimensional ADOS score. We further expected the larg-
est differences with the comparison group on the domain 
of social interaction and smaller differences on restricted 
and repetitive behavior as measured by the ADOS (Billst-
edt et al. 2007; Chowdhury 2010; Howlin et al. 2013). We 
found the scores on the ADOS to be higher in our ASD 
group when compared to our clinical non-ASD compari-
son group according to both the original and the revised 
algorithms, but overall considerably below the ASD cutoff 
on the SA and RBB scales. The difference in terms of the 
effect size was the smallest on the restricted repetitive behav-
ior scale of the revised algorithm. Furthermore, 81% of our 
ASD group fell outside the spectrum. In recent years several 
studies have been published regarding differences in ADOS 
scores according to both algorithms between patients with 
ASD and clinical comparison groups (Hus and Lord 2014; 
Pugliese et al. 2015; de Bildt et al. 2016; Fusar-Poli et al. 
2017). These studies showed a wide range of ASD clinical 
severity in the ASD groups. Comparing the revised algo-
rithm scores reported in these studies with those currently 
found, the social affect scale of both the ASD and clinical 
non-ASD comparison groups in the previous studies were 
higher than in our ASD group, while the restricted repeti-
tive behavior scores were similar to our results. Although 
we found no association between ADOS and ASBQ scores, 
in accordance with previous studies that did not find a rela-
tion between scores on an ASD questionnaire and observa-
tion scales (e.g. Ashwood et al. 2017; Morrier et al. 2017; 
Lever and Geurts 2018), this finding parallels the ASBQ 
finding that our ASD group differed from the clinical non-
ASD comparison group particularly in the social domain. 
We conclude that our young adults with a previous clinical 
PDD-NOS or Asperger diagnosis experienced higher levels 
of ASD problems, observed in particular by their parents, 
but that few met the formal criteria of the ADOS. Living-
ston and Happé (2017) recently suggested that the ADOS 
assessment situation (structured one-to-one interaction in a 
quiet space) may provide an optimal environment for com-
pensation of autistic social-cognitive difficulties. In more 
challenging social situations in real life, this compensation 
might fail, and behavioral problems can subsequently 
become manifest. This may at least in part explain the dis-
crepancy between ADOS and ASBQ scores. Another part 
of the explanation is that the ASD questionnaires sample 
behaviors over longer periods of time, while the duration 
of observation in the ADOS is brief. Nonetheless, the cur-
rent view is that to confirm or dismiss an ASD diagnosis 
the ADOS score should be part of a comprehensive clinical 
assessment (Kamp-Becker et al. 2018). Our findings suggest 
that the ADOS may identify relatively severe ASD problems 
and not the mild problems.
We expected that the ASD group would have substan-
tial comorbid psychiatric diagnoses (Hofvander et al. 2009; 
Lugnegård et al. 2011; Joshi et al. 2013; Lever and Geurts 
2016) and wanted to investigate potential differences from 
the clinical non-ASD comparison group. We found that the 
majority of both the participants with- and without ASD 
had at least one lifetime comorbid psychiatric disorder, and 
there were no differences in the prevalence of the various 
disorders assessed by the CIDI. This confirms findings 
in previous studies regarding comorbidity in adults with 
ASD and extends this for current milder forms, as has also 
been reported for children with PDD-NOS (Greaves-Lord 
et al. 2013). Mood and anxiety disorders occurred less in 
our group than in previous studies, but it is likely that part 
of the onsets of mood and anxiety disorders in our young 
adult group are still to come. The CIDI does not measure 
the presence of less prevalent psychopathology such as psy-
chotic disorders and eating disorders. Because of the grow-
ing interest in the co-occurrence of ASD with these disor-
ders in clinical practice it is an important subject for future 
research. Our results underline the conclusion of Louwerse 
et al. (2015) who emphasized the need to reevaluate psychi-
atric comorbidity during adolescence when a milder form 
of ASD is diagnosed in childhood.
Our results indicated that ASBQ scores in ASD par-
ticipants with a comorbid disorder (any DSM IV disorder 
lifetime according to CIDI) were on average higher than 
in those without psychiatric comorbidity; these differences 
reached significance in self-report (not other-report) on the 
subscales violation of social conventions, sensory stimu-
lation & motor stereotypies, insistence on sameness, and 
the total score. This finding might support the hypothesis 
that psychiatric comorbidity in ASD is related to more self-
reflection and -insight (e.g. Huang et al. 2017). Alterna-
tively, these higher scores may reflect the presence of more 
severe ASD problems in comorbid cases, as indicated by 
the self-reported ASD symptoms and the CIDI interview 
with the young adults themselves. That higher ASD scores 
go together with higher comorbid psychiatric problems has 
also been reported for children with PDD-NOS, based on 
parent report (Greaves-Lord et al. 2013; Verheij et al. 2015). 
However, our ASD participants with an ADOS score under 
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ASD cut-off had more psychiatric disorders according to 
CIDI score at T4 than those with an ADOS score above 
ASD cut-off. This finding suggests that the psychopatho-
logical symptoms of these patients with a previous PDD-
NOS or Asperger diagnosis later on in their life are better 
accounted for by another diagnosis. This is in contrast to 
those with persistent ASD according to ADOS who report 
less comorbidity.
Various studies have reported the functional outcome 
of ASD in adulthood to be poor or very poor (e.g. Smith 
et al 2012; Anderson et al. 2014), even though a consider-
able heterogeneity in course has been found. Compared to 
these findings, social and educational outcome at age 19 
in our ASD group appears to be less restricted when com-
pared to our clinical non-ASD comparison group and the 
normative group. Number of social contacts did not differ 
significantly between groups, nor did the number of par-
ticipants with a disability benefit. On the other hand, the 
percentage of young adults who received higher secondary 
education in the normative TRAILS group was higher (34%) 
than in both clinical groups, in the latter more participants 
received vocational education. When taking into account 
that IQ in our ASD group was higher than in the non-ASD 
group, educational outcome may be considered to be less 
than optimal. Further, the number of participants who had 
contacts with mental healthcare and who were on psychiat-
ric medication was significantly higher in the ASD group 
than in the clinical non-ASD comparison group suggesting 
a marked vulnerability to develop psychiatric symptomatol-
ogy that warrants therapeutic interventions. Our results bear 
some resemblance to those reported by Fein et al. (2013) on 
“optimal outcome” (OO) In their study 34 normal intelligent 
participants with a documented ASD diagnosis before the 
age of 5 who had lost their diagnosis at an average age of 
13 were then assessed by ADOS and other instruments. In 
adolescence no differences in social and language function-
ing and academic abilities were found when the OO group 
was compared to a group of typically developing individu-
als (Troyb et al. 2014), but OO participants showed subtle 
deficits in attention and self-control and less insight into 
social relationships (Orinstein et al. 2015a). Further, OO 
youth showed more past and current psychiatric symptoms 
and diagnoses than typically developing youth, especially 
attention and impulsivity symptoms (Orinstein et al. 2015b). 
The same applies to the study by Louwerse et al. (2015) in 
which they found stability of ADOS symptom severity from 
childhood into adolescence in a normal intelligent PDD-
NOS group referred to a university center. A large part of 
this group (46%) did not meet ADOS criteria for ASD clas-
sification in adolescence, but mental health care use and 
special educational needs were high. We refer to two view-
points described in the recent literature that may aid in the 
interpretation of our findings. Mandy (2017) suggested a 
moderating role of autistic traits in the development of non-
autistic psychopathology, which is, for example, apparent 
when a lack of mentalizing abilities and empathy may lead 
to the escalation of Oppositional Defiant Disorder traits into 
later antisocial behavior. From a transdiagnostic perspective, 
Van Os and Guloksuz (2017) hypothesized, in their critique 
of the “ultra high risk paradigm” (according to which the 
presence of psychotic experiences in youth pose a risk a 
for transition to schizophrenia), that psychotic experiences 
can be present in varying degrees as an early expression 
of nonspecific, multidimensional psychopathology. Just as 
Van Os and Guloksuz consider psychotic experiences to be 
a marker for the severity of non-psychotic psychopathology, 
autistic behaviors in children and adolescents with normal 
intelligence may have a similar meaning. More longitudi-
nal studies are needed that focus on the course of multiple 
dimensions of psychopathology through adolescence to 
clarify the relationship between autistic traits and other psy-
chopathology. Our findings support the DSM-5 delineating 
more stringent criteria for the diagnosis of ASD. A recent 
study into the symptom level of autism in 9-year old twins in 
Sweden indicated that over a decade, fewer autism symptom 
were required for a clinical diagnosis of autism (Arvidsson 
et al. 2018). Part of the group (who received their diagno-
sis based on DSM-IV) might not have been diagnosed with 
ASD according to the current rules of DSM-5. A study in 
childhood on the status of PDD-NOS in relation to DSM-5 
showed that subgroups of children with PDD-NOS would fit 
into categories of Social Communication Disorder, Disrup-
tive Mood Dysregulation Disorder, and ADHD, respectively 
(Greaves-Lord et al. 2013).
An important limitation of this study is that initial ASD 
diagnosis was made clinically according to the PCRNN 
and assessment was not systematically confirmed by us at 
that point in time by standardized diagnostic measures. The 
quality of diagnostic information obtained from the Case 
Register depends on clinical diagnostic practice, which in 
the Netherlands accords with the national clinical guide-
line stating that a best-estimate clinical diagnosis should be 
based on integrated information from different sources such 
as anamnesis, hetero-anamnesis and observation (Kan et al. 
2013). The around-to-above threshold-levels of SCQ scores 
for ASD at the time of inclusion in the study at age 11 appear 
to confirm the presence of significant autistic behavior in 
the ASD group. Nonetheless, in particular in light of the 
current threshold in DSM-5, ASD may have been diagnosed 
too often. A second limitation is the diagnostic heteroge-
neity of the clinical comparison group. A third limitation 
of this study is that the CIDI was used to assess comorbid 
psychopathology. While this is a well-validated structured 
interview for diagnosing common adult mental disorders, 
there is little experience with this instrument when admin-
istered in individuals diagnosed with ASD. The fact that the 
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prevalences of the various comorbid disorders were similar 
to those reported in the recent literature could tentatively 
be seen as an is indication of validity. Last, compared to 
previous studies, in which aspects like daily living skills and 
adaptive skills were examined, we explored a limited set of 
social and academic outcome variables, which means that 
no firm conclusions can be drawn about functional outcome.
In summary, this study shows that cognitively able young 
adults who were previously diagnosed with milder forms of 
ASD in secondary mental health care have higher scores 
on self-report, other-report and observation measures for 
ASD than clinical comparison subjects, but only a minority 
exceeds ASD cutoff according to ADOS. Psychiatric comor-
bidity does not differ between the groups, nor do social and 
educational functional outcomes, but the individuals diag-
nosed with ASD are more dependent on mental health care 
and young adults in this group use more psychiatric med-
ication. Our results add to the growing body of evidence 
indicating that part of cognitive able individuals with an 
ASD diagnosis in their youth no longer the behaviors that 
underscribe a clinical ASD diagnosis in adulthood, yet still 
exhibit subtle difficulties in social functioning and a vulner-
ability for a range of other psychiatric disorders.
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